Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
12.76
-0.22 (-1.69%)
At close: Apr 1, 2025, 4:00 PM
11.86
-0.90 (-7.03%)
After-hours: Apr 1, 2025, 4:38 PM EDT
Eton Pharmaceuticals Revenue
In the year 2024, Eton Pharmaceuticals had annual revenue of $39.01M with 23.29% growth. Eton Pharmaceuticals had revenue of $11.65M in the quarter ending December 31, 2024, with 59.26% growth.
Revenue (ttm)
$39.01M
Revenue Growth
+23.29%
P/S Ratio
8.62
Revenue / Employee
$1,258,419
Employees
31
Market Cap
342.19M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ETON News
- 11 hours ago - Eton Pharmaceuticals Out-Licenses International Rights to Increlex® - GlobeNewsWire
- 7 days ago - CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program - GlobeNewsWire
- 13 days ago - Eton Pharmaceuticals, Inc. (ETON) Virtual Investor Day and Q4 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results - GlobeNewsWire
- 18 days ago - Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600 - GlobeNewsWire
- 4 weeks ago - Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN® - GlobeNewsWire
- 4 weeks ago - Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025 - GlobeNewsWire
- 4 weeks ago - Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules - GlobeNewsWire